Correction: Fuzheng Huayu formula ameliorates chronic cholestatic liver injury by upregulating PPARa in mice

類似資料

• Correction: Fuzheng Huayu formula ameliorates chronic cholestatic liver injury by upregulating PPARa in mice
  著者:: Zheng Zhang, 等
  出版事項: (2026-05-01)
• The Adjunctive Efficacy of Fuzheng Huayu Tablet on Portal Hypertension with HBV Related Cirrhosis: A Protocol for a Multicenter Randomized Controlled Trial
  著者:: Li Z, 等
  出版事項: (2025-06-01)
• Fuzheng Huayu tablets for treating pulmonary fibrosis in post-COVID-19 patients: a multicenter, randomized, double-blind, placebo-controlled trial
  著者:: Fei Jing, 等
  出版事項: (2025-03-01)
• Fuzheng Huayu tablets reduces the risk of further decompensation after the first decompensation in patients with HBV-related cirrhosis: protocol for a randomized, double-blind, placebo-controlled, multicenter trial
  著者:: Lihua Yu, 等
  出版事項: (2026-07-01)
• Syndrome of liver depression and spleen deficiency is a primary TCM syndrome of response to entecavir + FuZheng HuaYu in patients with HBV-related liver fibrosis
  著者:: Yun-kai Dai, 等
  出版事項: (2023-11-01)